Medtronic has received US Food and Drug Administration (FDA) 510(k) clearance for its Aquamantys3 System as well as the new 8.2L Bipolar Sealer with Cutting and 6.0 Bipolar Sealer hand pieces.

The Aquamantys system offers surgeons and operating room staff enhanced features to improve ease of use, including a graphic user interface and an integrated cassette for simplified setup.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The new and existing hand pieces work on the company’s patented transcollation technology and radio frequency (RF) cutting functions, designed to provide hemostatic sealing of soft tissue and bone during surgery.

The addition of the 8.2L Bipolar Sealer with Cutting can potentially reduce device exchanges during surgery.

Medtronic Surgical Technologies division president Mark Fletcher said the Aquamantys System has been a valuable addition in the operating room, giving doctors the ability to better control intra-operative bleeding through transcollation technology.

"The new Aquamantys3 platform and the addition of 8.2L makes us even more valuable, and we look forward to the additional opportunities we can offer surgeons on this new product platform," Fletcher said.